Ernst Rudolf Berndt
Affiliations: | 1973-1980 | University of British Columbia, Vancouver, Vancouver, BC, Canada | |
| 1980- | Massachusetts Institute of Technology, Cambridge, MA, United States |
Website:
https://mitsloan.mit.edu/faculty/directory/ernst-rudolf-berndtGoogle:
"Ernst Berndt"Children
Sign in to add trainee| Erik Brynjolfsson | grad student | (Neurotree) | |
| Arthur Lewbel | grad student |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stern AD, Chen JL, Ouellet M, et al. (2021) Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users. Health Affairs (Project Hope). 40: 989-999 |
| Conti RM, Berndt ER. (2020) FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS. International Journal of the Economics of Business. 27: 27-48 |
| Frank RG, Hicks A, Berndt ER. (2020) The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines. Medical Care Research and Review : McRr. 1077558720921100 |
| Kaygisiz NB, Shivdasani Y, Conti RM, et al. (2019) The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications National Bureau of Economic Research |
| Adajar PM, Berndt ER, Conti RM. (2019) The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration National Bureau of Economic Research |
| Berndt ER, Conti RM, Murphy SJ. (2018) The generic drug user fee amendments: an economic perspective. Journal of Law and the Biosciences. 5: 103-141 |
| Bosworth B, Bieler J, Kleinrock M, et al. (2018) An Evaluation of the CPI Indexes for Prescription Drugs National Bureau of Economic Research |
| Berndt ER, Conti RM, Murphy SJ. (2017) The Landscape of US Generic Prescription Drug Markets, 2004-2016 National Bureau of Economic Research |
| Aitken M, Berndt ER, Cutler D, et al. (2016) Has The Era Of Slow Growth For Prescription Drug Spending Ended? Health Affairs (Project Hope). 35: 1595-603 |
| Berndt ER, Dubois P. (2016) Impacts of Patent Expiry on Daily Cost of Pharmaceutical Treatments in Eight OECD Countries, 2004–2010 International Journal of the Economics of Business. 23: 125-147 |